Dating the origin of the CCR5-Delta32 AIDS-resistance allele by the coalescence of haplotypes
- PMID:9585595
- PMCID: PMC1377146
- DOI: 10.1086/301867
Dating the origin of the CCR5-Delta32 AIDS-resistance allele by the coalescence of haplotypes
Abstract
The CCR5-Delta32 deletion obliterates the CCR5 chemokine and the human immunodeficiency virus (HIV)-1 coreceptor on lymphoid cells, leading to strong resistance against HIV-1 infection and AIDS. A genotype survey of 4,166 individuals revealed a cline of CCR5-Delta32 allele frequencies of 0%-14% across Eurasia, whereas the variant is absent among native African, American Indian, and East Asian ethnic groups. Haplotype analysis of 192 Caucasian chromosomes revealed strong linkage disequilibrium between CCR5 and two microsatellite loci. By use of coalescence theory to interpret modern haplotype genealogy, we estimate the origin of the CCR5-Delta32-containing ancestral haplotype to be approximately 700 years ago, with an estimated range of 275-1,875 years. The geographic cline of CCR5-Delta32 frequencies and its recent emergence are consistent with a historic strong selective event (e.g. , an epidemic of a pathogen that, like HIV-1, utilizes CCR5), driving its frequency upward in ancestral Caucasian populations.
Similar articles
- Frequency of CCR5-Delta32 deletion in human immunodeficiency virus type 1 (HIV-1) in healthy blood donors, HIV-1-exposed seronegative and HIV-1-seropositive individuals of southern Brazilian population.Reiche EM, Ehara Watanabe MA, Bonametti AM, Morimoto HK, Akira Morimoto A, Wiechmann SL, Matsuo T, Carvalho De Oliveira J, Vissoci Reiche F.Reiche EM, et al.Int J Mol Med. 2008 Nov;22(5):669-75.Int J Mol Med. 2008.PMID:18949389
- The case for selection at CCR5-Delta32.Sabeti PC, Walsh E, Schaffner SF, Varilly P, Fry B, Hutcheson HB, Cullen M, Mikkelsen TS, Roy J, Patterson N, Cooper R, Reich D, Altshuler D, O'Brien S, Lander ES.Sabeti PC, et al.PLoS Biol. 2005 Nov;3(11):e378. doi: 10.1371/journal.pbio.0030378. Epub 2005 Nov 1.PLoS Biol. 2005.PMID:16248677Free PMC article.
- Identification of the CCR5-Delta32 HIV resistance allele and new mutations of the CCR5 gene in different Tunisian populations.Jlizi A, Edouard J, Fadhlaoui-Zid K, Frigi S, Debré P, Slim A, Theodorou I, El Gaaied AB, Carpentier W.Jlizi A, et al.Hum Immunol. 2007 Dec;68(12):993-1000. doi: 10.1016/j.humimm.2007.10.003. Epub 2007 Oct 30.Hum Immunol. 2007.PMID:18191728
- The evolutionary history of the CCR5-Delta32 HIV-resistance mutation.Galvani AP, Novembre J.Galvani AP, et al.Microbes Infect. 2005 Feb;7(2):302-9. doi: 10.1016/j.micinf.2004.12.006. Epub 2005 Jan 8.Microbes Infect. 2005.PMID:15715976Review.
- The CRISPR-Cas9 induced CCR5 Δ32 mutation as a potent gene therapy methodology for resistance to HIV-1 variant: a review.Saifullah M, Laghzaoui O, Ozyahyalar H, Irfan A.Saifullah M, et al.Eur Rev Med Pharmacol Sci. 2024 Mar;28(6):2430-2463. doi: 10.26355/eurrev_202403_35751.Eur Rev Med Pharmacol Sci. 2024.PMID:38567606Review.
Cited by
- On the general theory of the origins of retroviruses.Wayengera M.Wayengera M.Theor Biol Med Model. 2010 Feb 16;7:5. doi: 10.1186/1742-4682-7-5.Theor Biol Med Model. 2010.PMID:20158888Free PMC article.
- The geographic spread of the CCR5 Delta32 HIV-resistance allele.Novembre J, Galvani AP, Slatkin M.Novembre J, et al.PLoS Biol. 2005 Nov;3(11):e339. doi: 10.1371/journal.pbio.0030339. Epub 2005 Oct 18.PLoS Biol. 2005.PMID:16216086Free PMC article.
- Pathogenesis of Yersinia pestis infection in BALB/c mice: effects on host macrophages and neutrophils.Lukaszewski RA, Kenny DJ, Taylor R, Rees DG, Hartley MG, Oyston PC.Lukaszewski RA, et al.Infect Immun. 2005 Nov;73(11):7142-50. doi: 10.1128/IAI.73.11.7142-7150.2005.Infect Immun. 2005.PMID:16239508Free PMC article.
- Intense selection in an age-structured population.Galvani AP, Slatkin M.Galvani AP, et al.Proc Biol Sci. 2004 Jan 22;271(1535):171-6. doi: 10.1098/rspb.2003.2573.Proc Biol Sci. 2004.PMID:15058394Free PMC article.
- Modeling the spatiotemporal spread of beneficial alleles using ancient genomes.Muktupavela RA, Petr M, Ségurel L, Korneliussen T, Novembre J, Racimo F.Muktupavela RA, et al.Elife. 2022 Dec 20;11:e73767. doi: 10.7554/eLife.73767.Elife. 2022.PMID:36537881Free PMC article.
References
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical